# Sacubitril-valsartan in Patients With Heart Failure.

> **NCT07341893** · NA · COMPLETED · sponsor: **Damanhour University** · enrollment: 60 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** Sacubitril-valsartan
- **DRUG:** standard treatment of heart failure

## Key facts

- **NCT ID:** NCT07341893
- **Lead sponsor:** Damanhour University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-08-01
- **Primary completion:** 2026-03-01
- **Final completion:** 2026-03-30
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2026-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07341893

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07341893, "Sacubitril-valsartan in Patients With Heart Failure.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07341893. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*